Monitor for any subsequent filings that may provide details on the securities cessation or unquoted securities changes. These notifications appear routine and are unlikely to have a material impact on the stock price.
Price Chart
Executive Summary
Alterity Therapeutics filed two 6-K reports on June 15, 2026, each containing an exhibit: one notification of cessation of securities and one notification regarding unquoted securities. The exhibits are image files with no extractable text, so the specific details are unavailable. These appear to be routine administrative filings related to the company's capital structure, with no material financial impact disclosed.
Key Facts
- Two 6-K filings submitted on June 15, 2026, both signed by Chairman Julian Babarczy.
- Exhibit 99.1 in the first filing: 'Notification of cessation of securities - ATH'.
- Exhibit 99.1 in the second filing: 'Notification regarding unquoted securities - ATH'.
- Both exhibits are image files; no textual details are available in the filing documents.
- Alterity Therapeutics is a development-stage biopharmaceutical company with a $65M market cap.
Financial Impact
No financial figures disclosed in the filing documents.
Risk Factors
- Lack of transparency due to image-only exhibits may obscure material changes to capital structure.
- Potential dilution or restructuring if the cessation or unquoted securities involve significant share counts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (ATHE) — Batch item 1 | 0001437749-26-020559 |
| Document: 0001437749-26-020559-index-headers.html | 0001437749-26-020558 |
| Document: 0001437749-26-020559-index.html | 0001437749-26-020559 |
| Document: 0001437749-26-020559.txt | 0001437749-26-020559 |
| 6-K Filing (ATHE) — Batch item 5 | 0001437749-26-020558 |
| Document: 0001437749-26-020558-index-headers.html | 0001437749-26-020559 |
| Document: 0001437749-26-020558-index.html | 0001437749-26-020559 |
| Document: 0001437749-26-020558.txt | 0001437749-26-020559 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (+1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.06 (−15.23%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.06 (−33.97%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.06 (−43.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers